Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
2',3'-cyclic nucleotide 3' phosphodiesterase | 0.604 | 0.692 | 0.98 |
|
disease | 0.400 | None | 0.400 | 5 | 0 | 2006 | 2018 | ||||||||
|
5-hydroxytryptamine receptor 1A | 0.522 | 0.846 | 0.20 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 1991 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 1F | 0.716 | 0.192 | 4.7E-03 |
|
disease | 0.370 | None | 0.500 | 2 | 0 | 1996 | 2004 | ||||||||
|
5-hydroxytryptamine receptor 2C | 0.555 | 0.692 | 3.7E-02 |
|
disease | 0.400 | None | 1.000 | 4 | 0 | 1995 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 3A | 0.608 | 0.538 | 1.7E-10 |
|
disease | 0.380 | None | 0.500 | 2 | 0 | 2001 | 2013 | ||||||||
|
5-hydroxytryptamine receptor 3B | 0.678 | 0.423 | 2.5E-07 |
|
disease | 0.350 | None | 1.000 | 1 | 0 | 2004 | 2017 | ||||||||
|
5-hydroxytryptamine receptor 3D | 0.839 | 0.077 | 5.0E-08 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
5-hydroxytryptamine receptor 3E | 0.839 | 0.077 | 4.2E-10 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2009 | 2010 | ||||||||
|
5-hydroxytryptamine receptor 4 | 0.610 | 0.615 | 2.5E-02 |
|
disease | 0.350 | None | 0.250 | 4 | 0 | 2002 | 2013 | ||||||||
|
5-hydroxytryptamine receptor 5A | 0.716 | 0.231 | 6.3E-03 |
|
disease | 0.360 | None | 1.000 | 4 | 0 | 2000 | 2016 | ||||||||
|
5-methyltetrahydrofolate-homocysteine methyltransferase | 0.482 | 0.808 | 2.4E-12 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
acetylcholinesterase (Cartwright blood group) | 0.445 | 0.885 | 1.00 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2015 | 2018 | ||||||||
|
acid phosphatase 1 | 0.566 | 0.731 | 1.8E-08 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 1990 | 2017 | ||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
disease | 0.390 | None | 1.000 | 1 | 0 | 2010 | 2020 | ||||||||
|
actin related protein 2 | 0.659 | 0.654 | 1.00 |
|
disease | 0.330 | None | 1.000 | 1 | 0 | 2014 | 2017 | ||||||||
|
activating transcription factor 4 | 0.507 | 0.769 | 1.6E-02 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2008 | 2020 | ||||||||
|
activator of transcription and developmental regulator AUTS2 | 0.569 | 0.846 | 1.00 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2011 | 2014 | ||||||||
|
activity dependent neuroprotector homeobox | 0.561 | 0.808 | 1.00 |
|
disease | 0.360 | None | 1.000 | 1 | 0 | 2011 | 2019 | ||||||||
|
activity regulated cytoskeleton associated protein | 0.573 | 0.769 | 0.59 |
|
disease | 0.370 | None | 1.000 | 1 | 0 | 2012 | 2019 | ||||||||
|
acyl-CoA synthetase long chain family member 6 | 0.686 | 0.500 | 3.2E-03 |
|
disease | 0.340 | None | 0.667 | 3 | 0 | 2006 | 2011 | ||||||||
|
acyl-CoA synthetase medium chain family member 1 | 0.769 | 0.269 | 2.3E-15 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2010 | 2015 | ||||||||
|
ADAM metallopeptidase domain 12 | 0.565 | 0.731 | 5.7E-07 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 12 | 0.700 | 0.462 | 2.5E-17 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
ADAMTS like 3 | 0.729 | 0.346 | 1.4E-19 |
|
disease | 0.410 | None | 1.000 | 1 | 0 | 2009 | 2019 | ||||||||
|
ADCYAP receptor type I | 0.561 | 0.769 | 7.2E-10 |
|
disease | 0.340 | None | 1.000 | 1 | 0 | 2007 | 2017 |